Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nina Lapke
PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients
Cancers
Cancer Research
Oncology
Advanced Lung Adenocarcinoma Patient With ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits From Trastuzumab
Case Reports in Oncological Medicine
Oncology
Related publications
Mutations in KRAS Codon 12 Predict Poor Survival in Chinese Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients
Frontiers in Oncology
Cancer Research
Oncology
Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Effect and Safety of Bevacizumab-Containing Chemotherapy Treatment in Chinese Patients With Metastatic Colorectal Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients With Metastatic Colorectal Cancer: Case Report
The Open Colorectal Cancer Journal
Biomarker Signatures Correlate With Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus
Molecular Cancer Therapeutics
Cancer Research
Oncology
